Coumestrol Composition Inhibits Adipocyte Differentiation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current compositions fail to effectively inhibit adipocyte differentiation, enhance immunity, detoxify toxic substances, and prevent or improve degenerative neurological disorders.
Innovation Solution
A composition comprising coumestrol or a bean extract, which inhibits adipocyte differentiation, enhances immunity, detoxifies toxic substances, and prevents or improves degenerative neurological disorders by utilizing coumestrol's estrogenic effects and phytoestrogen properties.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional compositions are used, then general health benefits are provided, but effective inhibition of adipocyte differentiation and prevention of degenerative neurological disorders is not achieved
Solution Approach 1:
The patent extracts coumestrol as the specific active ingredient from bean extracts and focuses on its isolated therapeutic effects. By identifying and utilizing coumestrol specifically (rather than using general bean extracts), the composition achieves reliable inhibition of adipocyte differentiation and prevention of neurological disorders while maintaining a relatively simple composition structure.
Solution Approach 2:
The patent optimizes the concentration of coumestrol in the composition to achieve maximum therapeutic effect. By carefully controlling the amount of coumestrol (0.01-10% by weight in food compositions, 0.1-100 mg per day in pharmaceutical compositions), the composition achieves reliable therapeutic effects without requiring complex multi-ingredient formulations.
2Reliability
If phytoestrogen-containing bean extracts are used, then hormonal disorder prevention is achieved, but effective detoxification of toxic substances and enhancement of immunity is not sufficient
Solution Approach 1:
The patent demonstrates that coumestrol possesses multiple therapeutic functions: it inhibits adipocyte differentiation, enhances immunity by activating immune cells, detoxifies toxic substances including nicotine, and prevents degenerative neurological disorders. This single active ingredient serves multiple health purposes, achieving versatility without requiring a complex mixture of different substances.
Solution Approach 2:
The patent optimizes coumestrol concentration to achieve maximum multi-functional effects. The specified concentration ranges (0.01-10% in foods, 0.1-100 mg/day in pharmaceuticals) are designed to simultaneously achieve all four therapeutic effects: adipocyte differentiation inhibition, immune enhancement, detoxification, and neurological protection.
3Reliability
If high concentrations of coumestrol are used, then therapeutic effects are enhanced, but safety and tolerability may be compromised
Solution Approach 1:
The patent carefully optimizes the concentration of coumestrol to achieve the maximum therapeutic effect while maintaining safety. The specified ranges (0.01-10% by weight in food compositions, 0.1-100 mg per day in pharmaceutical compositions) represent the optimal balance between efficacy and safety, ensuring reliable therapeutic effects without exceeding tolerable limits.
Solution Approach 2:
The patent positions coumestrol as a safe, naturally occurring phytoestrogen that can be used at relatively high concentrations compared to synthetic compounds. The substance's natural origin and established safety profile allow for higher effective doses without the same safety concerns as synthetic alternatives.
Data Source
AI summary
The present invention relates to a composition which comprises as an active ingredient coumestrol or a bean extract containing coumestrol, whereby adipocyte differentiation is inhibited, the immune system of the body is improved, toxic substances are purged, and neurodegenerative disorders are prevented or improved.